Guardian Pharmacy Services (NYSE:GRDN) Stock Rating Raised to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Guardian Pharmacy Services (NYSE:GRDN – Free Report) from a hold rating to a buy rating in a report released on Saturday morning,Wall Street Zen reports.

Several other equities research analysts also recently issued reports on the stock. KeyCorp started coverage on shares of Guardian Pharmacy Services in a research note on Tuesday, September 22nd. They set an “overweight” rating and a $52.00 price objective for the company. Truist Financial increased their price objective on shares of Guardian Pharmacy Services from $47.00 to $51.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. Weiss Ratings raised shares of Guardian Pharmacy Services from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, November 9th. Finally, Oppenheimer lifted their target price on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a report on Friday, August 7th. Nine equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, Guardian Pharmacy Services currently has an average rating of “Moderate Buy” and an average target price of $45.57.

Check Out Our Latest Stock Report on GRDN

Guardian Pharmacy Services Stock Up 0.4%

Shares of NYSE GRDN traded up $0.18 during midday trading on Friday, hitting $49.56. The stock had a trading volume of 339,069 shares, compared to its average volume of 508,603. Guardian Pharmacy Services has a 1-year low of $26.34 and a 1-year high of $50.58. The company has a market capitalization of $3.14 billion, a price-to-earnings ratio of 42.36, a PEG ratio of 2.58 and a beta of 0.06. The company has a fifty day moving average price of $42.48 and a 200 day moving average price of $38.78.

Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last posted its earnings results on Thursday, November 5th. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.31 by $0.02. Guardian Pharmacy Services had a net margin of 5.13% and a return on equity of 30.29%. The firm had revenue of $371.07 million during the quarter, compared to the consensus estimate of $365.76 million. On average, research analysts forecast that Guardian Pharmacy Services will post 1.18 EPS for the current year.

Hedge Funds Weigh In On Guardian Pharmacy Services

Several institutional investors and hedge funds have recently made changes to their positions in the business. Nisa Investment Advisors LLC increased its stake in shares of Guardian Pharmacy Services by 53.5% in the third quarter. Nisa Investment Advisors LLC now owns 1,050 shares of the company’s stock worth $43,000 after buying an additional 366 shares during the last quarter. State of Alaska Department of Revenue raised its holdings in Guardian Pharmacy Services by 105.9% in the third quarter. State of Alaska Department of Revenue now owns 2,390 shares of the company’s stock valued at $97,000 after acquiring an additional 1,229 shares in the last quarter. Voya Investment Management LLC acquired a new stake in Guardian Pharmacy Services in the third quarter valued at $238,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Guardian Pharmacy Services in the second quarter valued at $335,000. Finally, Arizona State Retirement System boosted its stake in Guardian Pharmacy Services by 53.0% during the 2nd quarter. Arizona State Retirement System now owns 8,393 shares of the company’s stock valued at $351,000 after acquiring an additional 2,907 shares during the last quarter.

Guardian Pharmacy Services Company Profile

(Get Free Report)

Guardian Pharmacy Services, Inc. provides pharmacy services to people living in long-term care and residential care settings. Its customers include assisted living and skilled nursing communities, behavioral health facilities, and other group-living providers. The company supplies prescription medications and offers medication packaging, delivery, consulting, and clinical support. Its services are designed to help care providers manage residents’ medication needs and support continuity of care. Founded in 2004, Guardian operates a network of pharmacies serving communities across the United States.

Recommended Stories

Analyst Recommendations for Guardian Pharmacy Services (NYSE:GRDN)

Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.